Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma.
Ladbury C, Dandapani S, Hao C, Fabros M, Amini A, Sampath S, Glaser S, Sokolov K, Yeh J, Baird JH, Kambhampati S, Herrera A, Mei M, Nikolaenko L, Shouse G, Budde LE.
Ladbury C, et al. Among authors: budde le.
Cancers (Basel). 2023 Mar 14;15(6):1747. doi: 10.3390/cancers15061747.
Cancers (Basel). 2023.
PMID: 36980632
Free PMC article.